IRIS
NAVARINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.217
NA - Nord America 3.513
EU - Europa 1.405
SA - Sud America 421
Continente sconosciuto - Info sul continente non disponibili 142
AF - Africa 82
OC - Oceania 22
Totale 11.802
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.256
US - Stati Uniti d'America 3.355
CN - Cina 896
IT - Italia 660
HK - Hong Kong 437
BR - Brasile 306
VN - Vietnam 193
GB - Regno Unito 184
BD - Bangladesh 158
FR - Francia 146
DE - Germania 101
CA - Canada 81
IN - India 79
NL - Olanda 79
MX - Messico 50
FI - Finlandia 38
AR - Argentina 34
ID - Indonesia 32
ES - Italia 30
TR - Turchia 27
ZA - Sudafrica 26
EC - Ecuador 24
JP - Giappone 24
AT - Austria 23
CO - Colombia 23
AU - Australia 19
UA - Ucraina 19
RU - Federazione Russa 18
PL - Polonia 17
EG - Egitto 13
PK - Pakistan 13
LT - Lituania 12
CZ - Repubblica Ceca 11
DK - Danimarca 11
PH - Filippine 11
IQ - Iraq 10
PE - Perù 10
SA - Arabia Saudita 10
CL - Cile 9
TN - Tunisia 9
IE - Irlanda 7
IR - Iran 7
JM - Giamaica 7
LB - Libano 7
SE - Svezia 7
UZ - Uzbekistan 7
BG - Bulgaria 6
LY - Libia 6
MA - Marocco 6
MY - Malesia 6
PY - Paraguay 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
HN - Honduras 5
JO - Giordania 5
MD - Moldavia 5
VE - Venezuela 5
BE - Belgio 4
DZ - Algeria 4
GT - Guatemala 4
IL - Israele 4
OM - Oman 4
TH - Thailandia 4
CR - Costa Rica 3
EE - Estonia 3
KE - Kenya 3
KZ - Kazakistan 3
RS - Serbia 3
TL - Timor Orientale 3
AL - Albania 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
ET - Etiopia 2
GH - Ghana 2
HR - Croazia 2
LK - Sri Lanka 2
LV - Lettonia 2
MM - Myanmar 2
NC - Nuova Caledonia 2
SV - El Salvador 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HT - Haiti 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
LC - Santa Lucia 1
Totale 11.644
Salva come PNG Salva come JPEG
Città #
San Jose 771
Ashburn 644
Singapore 614
Hong Kong 427
Rome 338
Dallas 271
Hefei 258
Beijing 246
Council Bluffs 233
Columbus 155
Boardman 136
London 121
Lauterbourg 115
Shanghai 83
Ho Chi Minh City 77
Santa Clara 63
Phoenix 60
Amsterdam 56
New York 52
Los Angeles 51
Munich 50
Hanoi 38
Mexico City 29
Milan 29
Naples 28
Toronto 25
Turku 23
Atlanta 22
São Paulo 22
Brooklyn 21
Washington 20
Pune 18
Ankara 17
Bari 17
Tokyo 17
Chicago 16
San Francisco 16
Frankfurt am Main 15
Warsaw 15
Haiphong 14
Buffalo 13
Helsinki 13
Las Vegas 13
Chennai 12
Hangzhou 12
Brasília 11
Johannesburg 10
Montreal 10
Nuremberg 10
Rio de Janeiro 10
Seattle 10
Boston 9
Changsha 9
Jinan 9
Vienna 9
Charlotte 8
Guangzhou 8
Jaguariúna 8
Orem 8
Philadelphia 8
Qingdao 8
West Jordan 8
Houston 7
Leicester 7
Miami 7
Quito 7
San Antonio 7
Turin 7
Baghdad 6
Bologna 6
Dammam 6
Dublin 6
Guayaquil 6
Melbourne 6
Paris 6
Tripoli 6
Cape Town 5
Champlin 5
Da Nang 5
Denver 5
Hải Dương 5
Madrid 5
Manaus 5
Pisa 5
Prague 5
Shijiazhuang 5
Tashkent 5
Amman 4
Augusta 4
Beirut 4
Belo Horizonte 4
Biên Hòa 4
Brno 4
Bắc Giang 4
Cairo 4
Calgary 4
Chaozhou 4
Chengdu 4
Cotia 4
Florence 4
Totale 5.636
Salva come PNG Salva come JPEG
Nome #
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 239
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 229
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 224
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 221
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 214
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 213
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 213
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 209
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 200
Leptin in immuno-rheumatological diseases 194
Adult-onset Still's disease with elderly onset: results from a multicentre study 186
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 178
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 176
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 175
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 173
Personal attitudes and denialist views about the COVID-19 pandemic in Italy: a national survey 153
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 151
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 150
A longitudinal study on caring behaviors of Italian nursing students 148
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 134
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry 128
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 126
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 124
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 123
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 122
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 120
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 119
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 119
Beauty is not perfection: what Leonardo’s Lady with an Ermine can suggest to aesthetic surgery 118
Pathogenesis of Psoriatic Arthritis 115
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 114
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 113
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 109
Development and implementation of the AIDA International Registry for patients with Behçet's disease 108
Cannabinoids in Autoimmune and Rheumatic Diseases 108
Leptin in autoimmune mechanisms of systemic rheumatic diseases 107
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 105
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis 102
Polypharmacy is a determinant of hospitalization in Parkinson's disease 102
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 101
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 96
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 96
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 95
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 91
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 86
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 85
Primary versus systemic-sclerosis-associated Raynaud's phenomenon: relationship with clinical and environmental factors 79
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 78
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 78
The Association of Olfactory Dysfunction, Frailty, and Mortality Is Mediated by Inflammation: Results from the InCHIANTI Study 78
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 77
Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 77
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 77
Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort 77
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 75
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 73
Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based Review 69
Euthymic despite pain: the role of cognitive reappraisal and experiential avoidance in autoimmune inflammatory rheumatic diseases—a cross-sectional study 68
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 68
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 68
Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients 67
Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study 67
Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry 65
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 65
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 65
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 64
From pain catastrophising to multidimensional psychological distress: unravelling the complexity of difficult-to-treat psoriatic arthritis 63
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 62
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 62
Phase angle could be a marker of microvascular damage in systemic sclerosis 62
The Patrick-FABER test in detecting active sacroiliitis in spondyloarthritis patients: a prospective study using magnetic resonance as reference standard 62
Erythema Multiforme Induced by Secukinumab: Clinical, Dermoscopic, and Histological Features 61
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 61
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres 60
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 60
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 60
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 60
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 60
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 60
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 59
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry 59
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 59
Necrobiosis-Lipoidica-Like Skin Lesions in a Patient with Non-Systemic Sarcoidosis 58
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 58
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 58
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 58
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 57
Development and Implementation of the AIDA International Registry for Patients With Still's Disease 57
Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future 56
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 56
Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis 56
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 55
LOW-DOSE ASPIRIN MAY HAVE A ROLE AS PRIMARY PROPHYLAXIS OF CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS: EVIDENCE FROM AN ITALIAN MULTICENTRIC RETROSPECTIVE STUDY 55
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 54
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 54
Inflammation as a mediator of the association between osteoporosis and hearing loss in older subjects: a population-based study 54
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 54
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 53
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 53
Endothelial-to-mesenchymal transition in systemic sclerosis 53
Totale 10.016
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.960
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022116 0 0 0 0 0 0 2 4 21 6 2 81
2022/2023165 1 0 5 4 60 0 6 5 6 7 63 8
2023/2024422 16 53 18 50 45 164 8 18 7 12 21 10
2024/20254.807 49 58 141 90 92 131 73 21 321 328 1.545 1.958
2025/20265.057 490 229 479 528 232 279 1.263 311 325 441 315 165
2026/20271.232 94 448 497 193 0 0 0 0 0 0 0 0
Totale 11.802